US Bancorp’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344 Buy
+64
New +$294 ﹤0.01% 4039
2025
Q3
Sell
-5,470
Closed -$19.7K 4024
2025
Q2
$19.7K Sell
5,470
-540
-9% -$1.61K ﹤0.01% 3172
2025
Q1
$18K Buy
+6,010
New +$18.8K ﹤0.01% 3216
2024
Q2
Sell
-2,900
Closed -$11.7K 3979
2024
Q1
$11.7K Buy
+2,900
New +$11.3K ﹤0.01% 3284
2023
Q3
Sell
-1,015
Closed -$3.8K 3989
2023
Q2
$3.8K Buy
+1,015
New +$3.8K ﹤0.01% 3553
2023
Q1
Sell
-264
Closed -$1.27K 4086
2022
Q4
$1.27K Sell
264
-100
-27% -$506 ﹤0.01% 3882
2022
Q3
$2K Buy
+364
New +$2.79K ﹤0.01% 3798
2022
Q2
Sell
-207
Closed -$1K 4074
2022
Q1
$1K Sell
207
-42
-17% -$285 ﹤0.01% 3911
2021
Q4
$2K Buy
249
+202
+430% +$3.15K ﹤0.01% 3863
2021
Q3
$2K Buy
47
+32
+213% +$888 ﹤0.01% 3854
2021
Q2
$0 Buy
+15
New +$451 ﹤0.01% 3990

Other funds holding AVIR